Stay updated on ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Sign up to get notified when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.

Latest updates to the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page
- Check5 days agoChange DetectedThe updates appear to be minor formatting and text adjustments on the Study Details page, with no changes to the study design, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check34 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference2%

- Check41 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check55 days agoChange DetectedThe page version has been updated to v3.0.2, replacing v3.0.1. The 'Back to Top' navigation element has been removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.SummaryDifference0.1%

- Check70 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as a detailed publication related to a clinical study. Some previous location names and terms have been removed, indicating a refinement in the information presented.SummaryDifference5%

Stay in the know with updates to ABP 654 for Psoriasis: Moderate-Severe Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ABP 654 for Psoriasis: Moderate-Severe Clinical Trial page.